MAP2K3 and neoplasm: Furthermore, the loss of MKK3 copy number was significantly more frequent in squamous cell carcinoma (SQ) and large cell carcinoma (LC) than in adenocarcinoma (AD), suggesting the potential value of MKK3 as a novel tumor suppressor in NSCLC [41].